Resources from the same session
1539MO - Oncologists’ voices in time of crisis: Findings from the ESMO Resilience Task Force survey series on how members can be helped and supported – A qualitative analysis
Presenter: Claire Hardy
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1540MO - The patient voice: An analysis of real-world data using the recurrent respiratory papillomatosis foundation/CoRDS patient registry (RRPF/CoRDS)
Presenter: Sara Pai
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Webcast
1541MO - Leadership roles in oncology: Gender is still a barrier. Results from the new ESMO Women for Oncology Committee authorship and monitoring studies
Presenter: Helena Linardou
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1542MO - Mapping the scale of off-label use in oncology: An important step in harmonising access
Presenter: Hans Timmer
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1543MO - Analysis of concordance between trial and target populations for cancer drugs in the US, EU, and Switzerland (2014-2023)
Presenter: Kerstin Vokinger
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1544MO - Clinical trial design and treatment effects: A meta-analysis of randomized-controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications
Presenter: Julia Caroline Michaeli
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Webcast
Invited Discussant 1542MO, 1543MO and 1544MO
Presenter: Paolo G. Casali
Session: Mini oral session: Policy and preventive strategies
Resources:
Slides
Webcast
LBA64 - Outcomes of BRCA and in-house homologous recombination deficiency (HRD) testing in women with ovarian and breast cancer: A multicentre registry study
Presenter: Kyrillus Shohdy
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1545MO - Personalised cancer prevention programme (Interception): A cost analysis to inform public policy decision-making
Presenter: Farah Erdogan
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA64 and 1545MO
Presenter: Judith Balmaña
Session: Mini oral session: Policy and preventive strategies
Resources:
Slides
Webcast